It is a pharma private limited company based in Kolhapur, Maharashtra, India, established in 2017.
2017 | Kolhapur, Maharashtra, India | ActiveElixa Medicaments Private Limited, a active private limited company, was established on 10 October 2017 in Kolhapur, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U33309PN2017PTC172931. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹4.50 M and a paid-up capital of ₹1.17 M.
It upholds a compliant status. Its leadership includes Rajiv Vijayraj Deshpande (Director), Rashmi Rajiv Deshpande (Director). Past directors included Shreya Rajiv Deshpande. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at Csno814/2/1Awingorchidhomesfl.No.104Eward,Karandemala, Kolhapur, Maharashtra, 416003.
U33309PN2017PTC172931
172931
10 October 2017
₹4.50 M
₹1.17 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Elixa Medicaments Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajiv Vijayraj Deshpande | Director | 18 Mar 2020 | Current |
| Rashmi Rajiv Deshpande | Director | 10 Oct 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Apr 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Elixa Medicaments Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 82.05% increase. The company also saw a substantial improvement in profitability, with a 16.16% increase in profit. The company's net worth moved up by a moderate rise of 7.13%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Elixa Medicaments had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Elixa Medicaments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Elixa Medicaments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elixa Medicaments's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Elixa Medicaments Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was recorded as a recent event.
Elixa Medicaments Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Pune. was recorded as a recent event.
The activity Rajiv Vijayraj Deshpande was appointed as a Director was appointed as a Director on 18 Mar 2020 & has been associated with this company since 5 years 9 months . was completed.
The activity Rashmi Rajiv Deshpande was appointed as a Director was appointed as a Director on 10 Oct 2017 & has been associated with this company since 8 years 2 months . was completed.
The activity Elixa Medicaments Private Limited was registered on 10 Oct 2017 with Roc Pune & aged 8 years 2 months as per MCA records. was completed.
The CIN of Elixa Medicaments Private Limited is U33309PN2017PTC172931.
Elixa Medicaments Private Limited is headquartered at Csno814/2/1Awingorchidhomesfl.No.104Eward,Karandemala, Kolhapur, Maharashtra, 416003.
Elixa Medicaments Private Limited was incorporated on 10 October 2017.
The current directors of Elixa Medicaments Private Limited are
The primary industry of Elixa Medicaments Private Limited is Manufacturing.
Elixa Medicaments Private Limited is unlisted.
The authorized capital of Elixa Medicaments Private Limited is ₹4.50 M, and the paid-up capital is ₹1.17 M.
The compliance status of Elixa Medicaments Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX